Indefinite Delivery Contract 36C24E20D0017

The Department of Veterans Affairs Veterans Health Administration awarded an indefinite delivery contract to Quest Diagnostics Incorporated to provide mobile blood collection services in support of COVID-19 testing for veterans. The single award IDV has a potential value of $889,725 and a period of performance through June 2023. Eight firm fixed price delivery orders were issued against the contract or unspecified contract vehicles by VISN 4 and VA Headquarters for mobile phlebotomy and specimen collection from locations in Pennsylvania and New Jersey. The delivery orders have values ranging from $0 to $640,602 and support COVID-19 response efforts under the national interest action code through completion dates between September 2020 and August 2022. As prime contractor, Quest Diagnostics will utilize its medical expertise and infrastructure to mobilize phlebotomists and necessary equipment to designated testing locations to help the VA monitor the impact of the pandemic. No subcontractors or socioeconomic set-asides were specified in the awards.

The originating solicitation sought mobile blood collection services with a response due date of May 6, 2020 and anticipated award date of June 5, 2020. The single award IDV and subsequent delivery orders facilitate critical COVID-19 testing for veterans without socioeconomic restrictions to obtain testing capacity on an urgent basis. Quest Diagnostics leverages its experience and scale as the leading diagnostic information services provider to directly support the health and safety of those served by the VA healthcare system during the ongoing public health emergency.